Abstract: An AUV includes: an underwater vehicle main body configured to sail along an inspection object located in water or on the bottom of the water; an arm extending from the underwater vehicle main body; an inspection tool portion including a contact portion configured to contact the inspection object and an inspection device configured to inspect the inspection object; and a passive joint provided between the arm and the inspection tool portion and configured to allow passive rotation of the inspection tool portion relative to the arm about at least one axis.

Abstract: An electronic device includes a battery pack, a charging circuit that charges the battery pack, a load device that operates with a power of the battery pack, a voltage sensor that detects a charge voltage and a discharge voltage of the battery pack, a current sensor that detects a charge current and a discharge current of the battery pack, and a control circuit. The control circuit calculates an internal resistance of the battery pack based on the charge voltage and the charge current, calculates an allowable power indicating a maximum power that is able to be acquired from the battery pack by the load device based on the discharge voltage, the discharge current, and the internal resistance, and sends a control signal to the load device to cause the load device to operate with a power less than or equal to the allowable power.

Abstract: A method of operation of an electronic system includes: detecting a sensing factor within a presentation context; determining a device relationship based on the sensing factor for establishing the device relationship between multiple instances of a device; and generating a presentation arrangement with a control unit for presenting a color arrangement at a luminosity level according to the device relationship for presenting on the device.

Abstract: The present invention provides a novel active ingredient which can be safely used in preventing, ameliorating or treating diseases related to the cartilage such as cartilage damages and cartilage disorders. Since the egg yolk protein hydrolyzate has an effect on chondrocyte proliferation promotion, it is useful as an active ingredient for preventing, ameliorating or treating cartilage disorders and for preventing, ameliorating or treating joint pain. The egg yolk protein hydrolyzate is a natural-origin material with high safety and, therefore, can be widely used in foods and drinks, medicines, feeds and the like which can be daily ingested.

Abstract: The present invention provides a novel active ingredient which can be safely used in preventing, ameliorating or treating diseases related to the cartilage such as cartilage damages and cartilage disorders. Since the egg yolk protein hydrolyzate has an effect on chondrocyte proliferation promotion, it is useful as an active ingredient for preventing, ameliorating or treating cartilage disorders and for preventing, ameliorating or treating joint pain. The egg yolk protein hydrolyzate is a natural-origin material with high safety and, therefore, can be widely used in foods and drinks, medicines, feeds and the like which can be daily ingested.

Abstract: A hole formation method including applying a pillar-forming liquid to a base material, to thereby form a pillar; applying an insulating film-forming material to the base material on which the pillar has been formed, to thereby form an insulating film; removing the pillar to form an opening in the insulating film; and heat treating the insulating film in which the opening has been formed.

Abstract: A hole formation method including applying a pillar-forming liquid to a base material, to thereby form a pillar; applying an insulating film-forming material to the base material on which the pillar has been formed, to thereby form an insulating film; removing the pillar to form an opening in the insulating film; and heat treating the insulating film in which the opening has been formed.

Abstract: The object of the present invention is to develop a technique for expressing a functional membrane-bound protein by using baculovirus and insect cell expression system. The present invention provides a method for expressing a functional membrane-bound receptor protein which comprises steps of culturing a host infected with at least one type of recombinant baculovirus which contains a gene encoding an interacting protein and a gene encoding a membrane-bound receptor protein which interacts with said interacting protein to perform its function, and co-expressing said interacting protein and said membrane-bound receptor protein in a budded baculovirus released from said host.

Abstract: The object of the present invention is to develop a technique for expressing a functional membrane-bound protein by using baculovirus and insect cell expression system. The present invention provides a method for expressing a functional membrane-bound receptor protein which comprises steps of culturing a host infected with at least one type of recombinant baculovirus which contains a gene encoding an interacting protein and a gene encoding a membrane-bound receptor protein which interacts with said interacting protein to perform its function, and co-expressing said interacting protein and said membrane-bound receptor protein in a budded baculovirus released from said host.